Beximco Pharma Share News (BXP)

Beximco Pharma Information

Buy BXP Shares
Add BXP to Watchlist
Add BXP to Alert

Share Price Information for Beximco Pharma (BXP)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 37.50

Bid: 36.00

Ask: 39.00

Change: 0.00 (0.00%)

Spread: 3.00 (8.333%)

Open: 0.00

High: 0.00

Low: 0.00

Prev. Close: 37.50

Last checked at -

Monday broker round-up

Mon, 23rd Jul 2018 12:53

(Sharecast News) - Hargreaves Lansdown: Jefferies downgrades to underperform with a target price of 1,650p.WPP: Berenberg reiterates sell with a target price of 1,075p.McColl's Retail Group: Liberum downgrades to hold with a target price of 200p.Sthree: Liberum reiterates buy with a target price of 430p.IWG: Peel Hunt reiterates hold with a target price of 285p.Helical Bar: Peel Hunt reiterates buy with a target price of 425p.Ascential: Peel Hunt reiterates buy with a target price of 515p.Acacia: Numis reiterates buy with a target price of 250p.Hammerson: Numis reiterates hold with a target price of 590p.Midwich: Canaccord downgrades to hold with a target price of 707p.Petra Diamonds: Canaccord reiterates buy with a target price of 80p.Tungsten Corp: Canaccord reiterates buy with a target price of 92p.Beximco Pharmaceuticals: Northland Capital Markets reiterates buy with a target price of 84p.Man Group: Jefferies upgrades to buy with a target price of 214p.Jupiter Fund Management: Jefferies downgrades to hold with a target price of 480p.GlaxoSmithKline: UBS reiterates buy with a target price of 1,600p.Cairn Energy: UBS reiterates buy with a target price of 300p.Paragon Banking Group: UBS reiterates buy with a target price of 525p.LSE: Berenberg reiterates buy with a target price of 4,690p.Moneysupermarket.com: Berenberg reiterates hold with a target price of 275p.

More News

13 Nov 2020 12:05

Beximco Posts Higher Quarterly Earnings Despite Covid-19 Challenges

11 Nov 2020 14:54

IN BRIEF: Beximco Pharmaceuticals Posts Double-Digit Annual Sales Rise

5 Nov 2020 22:32

UK TRADING UPDATE SUMMARY: Beximco In Bangladesh Vaccine Supply Pact

21 Sep 2020 19:29

UK TRADING UPDATE SUMMARY: Record In Talks For Bumper Hedging Deal

28 Aug 2020 14:33

IN BRIEF: Beximco To Be Exclusive Covid Vaccine Supplier In Bangladesh

30 Jul 2020 18:00

UK EXECUTIVE CHANGE SUMMARY: 65-Year Stint At Heavitree Brewery Ends

4 May 2020 12:10

UK TRADING UPDATE SUMMARY: Science Group's UK Ventilator Plan Stalls

24 Feb 2020 12:00

Beximco To Distribute Mylan Product Portfolio In Bangladesh

29 Jan 2020 11:29

Beximco Pharmaceuticals Earnings Rise Amid Spate Of Product Launches

14 Nov 2019 11:14

Beximco Pharma Reports "Strong" Start To Year As Quarterly Earnings Up

11 Nov 2019 09:44

Beximco Pharmaceuticals Outlook Confident As Earnings Improve In Year

4 Nov 2019 15:58

UK Earnings, Trading Statements Calendar - Next 7 Days

24 Apr 2019 15:41

Beximco gets FDA approval for generic anti-allergy drug

(Sharecast News) - Beximco Pharmaceuticals announced on Wednesday that it has received US Food and Drug Administration (FDA) approval for its cyproheptadine hydrochloride tablet 4mg anti-allergy drug, which is a generic equivalent to 'Periactin' 4mg tablets from Merck and Company.

20 Feb 2019 14:46

Beximco adds to US portfolio with purchase of Novartis assets

(Sharecast News) - Generic drugs manufacturer Beximco Pharmaceuticals announced the signing of a definitive agreement with Sandoz - a division of Novartis - to acquire a portfolio of eight 'Abbreviated New Drug Applications' (ANDAs) in the US on Wednesday, for an undisclosed amount in cash.

30 Jul 2018 13:17

Monday broker round-up

(Sharecast News) - Sophos Group: Numis upgrades to add with a target price of 580p.

Latest Share Chat

Beximco Pharma Share News (BXP)

Share Price Information for Beximco Pharma (BXP)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Monday broker round-up

Login to your account

Quickpicks are a member only feature

Login to your account